Quick Answer
Vivani Medical, Inc. reported Diluted EPS of $0.43 per share (loss) for fiscal year 2025.
Vivani Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.43 | +0.0% |
| 2024 | -$0.43 | +14.0% |
| 2023 | -$0.50 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.11 | +0.0% | +8.3% |
| June 30, 2025 | -$0.12 | -20.0% | -9.1% |
| March 31, 2025 | -$0.11 | +8.3% | +0.0% |
| September 30, 2024 | -$0.11 | +15.4% | -10.0% |
| June 30, 2024 | -$0.10 | +23.1% | +16.7% |
| March 31, 2024 | -$0.12 | — | +7.7% |
| September 30, 2023 | -$0.13 | -425.0% | +0.0% |
| June 30, 2023 | -$0.13 | — | -425.0% |
- Vivani Medical, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Vivani Medical, Inc.’s diluted eps has grown by 14.0% (from $0.50 per share (loss) to $0.43 per share (loss)).
- The most recent figure is from Vivani Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: